Andexanet alfa demonstrated safety and effectiveness in Japanese patients with major bleeding associated with Factor Xa inhibitor treatment.
Does andexanet alfa improve safety and effectiveness in Japanese patients with FXaI-associated major bleeds?
Andexanet alfa appears safe and effective for managing FXaI-associated major bleeds in a real-world Japanese cohort.
Absolute Event Rate: 0% vs 0%
This study supports the safety and effectiveness of andexanet alfa in a real-world population of Japanese patients with FXaI-associated major bleeds.
Sakamoto et al. (Sun,) reported a other. Andexanet alfa demonstrated safety and effectiveness in Japanese patients with major bleeding associated with Factor Xa inhibitor treatment.